SCHEMBL5700584

SCHEMBL5700584

CCCCC[C@H](O)C=C[C@H]1C(=O)C=C[C@@H]1CC=CCCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 1.00
UCHL3 P15374 1/20 1.00
GALR3 O60755 1/20 0.76
ALDH1A1 P00352 5/20 0.73
TRPA1 O75762 4/20 0.73
HPGD P15428 2/20 0.73
LMNA P02545 2/20 0.73
MEN1 O00255 1/20 0.73
POLB P06746 1/20 0.73
NR4A1 P22736 1/20 0.73
PTPN7 P35236 1/20 0.73
KMT2A Q03164 1/20 0.73
SMN1; SMN2 Q16637 1/20 0.73
HIF1A Q16665 1/20 0.73
SLCO2A1 Q92959 2/20 0.62
PTGDR2 Q9Y5Y4 1/20 0.62
PTGER4 P35408 4/20 0.56
PTGER2 P43116 3/20 0.56
PTGER1 P34995 3/20 0.56
PTGER3 P43115 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13649348 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL8350588 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL22607967 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL13905975 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL5700581 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL25608056 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL8350586 1.00 MAPT (1.00) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL14948544 0.92 MAPT (0.85) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL10865862 0.92 MAPT (0.85) MAPTUCHL3GALR3ALDH1A1TRPA1
SCHEMBL11119548 0.92 MAPT (0.85) MAPTUCHL3GALR3ALDH1A1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954844-A (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters G. D. SEARLE & CO. (US) 1976-05-04 US claimed
EP-1310256-B1 Use of prostaglandin A or its derivatives for the treatment of psoriasis SYNPHORA AB (SE) 2006-06-21 EP disclosed
EP-1310256-A2 Use of prostaglandin A or its derivatives for the treatment of psoriasis Synphora AB (SE) 2003-05-14 EP disclosed
EP-0778774-B1 NEW USE OF PROSTAGLANDINS SYNPHORA AB (SE) 2003-04-09 EP disclosed
EP-0782447-B1 USE OF PROSTAGLANDINS FOR THE MANUFACTURE OF A MEDICAMENT FOR PREVENTION AND TREATMENT OF SECONDARY CATARACT SYNPHORA AB (SE) 2002-02-27 EP disclosed
US-6031001-A Use of prostaglandins SYNPHRA AB (SE) 2000-02-29 US disclosed
US-5760075-A Method and means for prevention and treatment of secondary cataract PHARMACIA & UPJOHN AB (SE) 1998-06-02 US disclosed
US-3954844-A (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters G. D. SEARLE & CO. (US) 1976-05-04 US disclosed
US-3954844-A (5Z,13E,15S)-15-Hydroxy-11-oxoprosta-5,9.13-trien-1-oic acid and esters G. D. SEARLE & CO. (US) 1976-05-04 US disclosed